ARCHIVES

In Brief: Recompetition Of Frederick Contract Flops, As Others Leave The Field To Litton-Bionetics

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

New Concepts Being Developed By Organ Systems Groups Described

January 2, 1987

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

March 6, 1998

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010